These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2572025)

  • 1. Cerebrospinal fluid somatostatin in delirium.
    Koponen H; Stenbäck U; Mattila E; Reinikainen K; Soininen H; Riekkinen PJ
    Psychol Med; 1989 Aug; 19(3):605-9. PubMed ID: 2572025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid somatostatin in delirium. II. Changes at the acute stage and at one year follow-up.
    Koponen H; Reinikainen K; Riekkinen PJ
    Psychol Med; 1990 Aug; 20(3):501-5. PubMed ID: 1978369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A long-term follow-up study of cerebrospinal fluid somatostatin in delirium.
    Koponen HJ; Leinonen E; Lepola U; Riekkinen PJ
    Acta Psychiatr Scand; 1994 May; 89(5):329-34. PubMed ID: 7915078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin-like immunoreactivity and substance-P-like immunoreactivity in the CSF of patients with senile dementia of Alzheimer type, multi-infarct syndrome and communicating hydrocephalus.
    Cramer H; Schaudt D; Rissler K; Strubel D; Warter JM; Kuntzmann F
    J Neurol; 1985; 232(6):346-51. PubMed ID: 2416886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular size distribution of somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with degenerative brain disease.
    Rissler K; Cramer H; Schaudt D; Strubel D; Gattaz WF
    Neurosci Res; 1986 Feb; 3(3):213-25. PubMed ID: 2871533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF beta-endorphin-like immunoreactivity in delirium.
    Koponen H; Stenbäck U; Mattila E; Reinikainen K; Soininen H; Riekkinen PJ
    Biol Psychiatry; 1989 Apr; 25(7):938-44. PubMed ID: 2524220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF somatostatin-like immunoreactivity in dementia.
    Beal MF; Growdon JH; Mazurek MF; Martin JB
    Neurology; 1986 Feb; 36(2):294-7. PubMed ID: 2868429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A long-term follow-up study of cerebrospinal fluid 5-hydroxyindoleacetic acid in delirium.
    Koponen HJ; Lepola U; Leinonen E
    Eur Arch Psychiatry Clin Neurosci; 1994; 244(3):131-4. PubMed ID: 7528542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced cholinesterase activity and somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with dementia of the Alzheimer type.
    Soininen HS; Jolkkonen JT; Reinikainen KJ; Halonen TO; Riekkinen PJ
    J Neurol Sci; 1984 Feb; 63(2):167-72. PubMed ID: 6142929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatostatin cerebrospinal fluid levels in dementia.
    Molins A; Catalán R; Sahuquillo J; Castellanos JM; Codina A; Galard R
    J Neurol; 1991 Jun; 238(3):168-70. PubMed ID: 1678420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatin-like immunoreactivity in the CSF of patients with dementia associated with alcoholism.
    Koponen H; Reinikainen KJ; Jolkkonen JT; Riekkinen PJ
    Acta Neurol Scand; 1990 Nov; 82(5):289-91. PubMed ID: 2281744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in cerebrospinal fluid concentrations of somatostatinlike immunoreactivity in neuropsychiatric disorders.
    Bissette G; Widerlöv E; Walléus H; Karlsson I; Eklund K; Forsman A; Nemeroff CB
    Arch Gen Psychiatry; 1986 Dec; 43(12):1148-51. PubMed ID: 3778111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin-like immunoreactivity in lumbar cerebrospinal fluid from neurohistologically examined demented patients.
    Francis PT; Bowen DM; Neary D; Palo J; Wikstrom J; Olney J
    Neurobiol Aging; 1984; 5(3):183-6. PubMed ID: 6151122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin-like immunoreactivity and acetylcholinesterase activities in cerebrospinal fluid of patients with Alzheimer disease and senile dementia of the Alzheimer type.
    Gomez S; Davous P; Rondot P; Faivre-Bauman A; Valade D; Puymirat J
    Psychoneuroendocrinology; 1986; 11(1):69-73. PubMed ID: 3517922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased somatostatin-like immunoreactivity in the cerebrospinal fluid of chronic schizophrenic patients with cognitive impairment.
    Reinikainen KJ; Koponen H; Jolkkonen J; Riekkinen PJ
    Psychiatry Res; 1990 Sep; 33(3):307-12. PubMed ID: 2243905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular forms of somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with senile dementia of the Alzheimer type.
    Strittmatter M; Cramer H; Reuner C; Strubel D; Hamann G; Schimrigk K
    Biol Psychiatry; 1997 Jun; 41(11):1124-30. PubMed ID: 9146823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid neuropeptides in mood disorder and dementia.
    Banki CM; Karmacsi L; Bissette G; Nemeroff CB
    J Affect Disord; 1992 May; 25(1):39-45. PubMed ID: 1352520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid somatostatin and neuropeptide Y. Concentrations in aging and in dementia of the Alzheimer type with and without extrapyramidal signs.
    Atack JR; Beal MF; May C; Kaye JA; Mazurek MF; Kay AD; Rapoport SI
    Arch Neurol; 1988 Mar; 45(3):269-74. PubMed ID: 2893600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EEG spectral analysis in delirium.
    Koponen H; Partanen J; Pääkkönen A; Mattila E; Riekkinen PJ
    J Neurol Neurosurg Psychiatry; 1989 Aug; 52(8):980-5. PubMed ID: 2795067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prednisone decreases CSF somatostatin in healthy humans: implications for neuropsychiatric illness.
    Wolkowitz OM; Rubinow DR; Breier A; Doran AR; Davis C; Pickar D
    Life Sci; 1987 Oct; 41(16):1929-33. PubMed ID: 2889125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.